It has previously been reported that PDE4 inhibitors have a greater effect in COPD patients with higher eosinophil counts4, 10 and that PDE4 inhibition can reduce airways eosinophil numbers.12, 13. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.